NG
WST icon

Norden Group’s West Pharmaceutical WST Stock Holding History

Norden Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Sell
3,409
-759
-18% -$232K 0.1% 182
2026
Q1 		$1.04M Buy
4,168
+382
+10% +$95K 0.1% 184
2025
Q4 		$1.04M Sell
3,786
-86
-2% -$23.5K 0.1% 181
2025
Q3 		$1.02M Sell
3,872
-100
-3% -$24.3K 0.1% 187
2025
Q2 		$869K Sell
3,972
-1,432
-26% -$306K 0.09% 213
2025
Q1 		$1.21M Sell
5,404
-290
-5% -$79.9K 0.14% 144
2024
Q4 		$1.87M Buy
5,694
+157
+3% +$49.4K 0.21% 96
2024
Q3 		$1.66M Buy
5,537
+3,833
+225% +$1.17M 0.2% 110
2024
Q2 		$561K Sell
1,704
-625
-27% -$221K 0.11% 199
2024
Q1 		$922K Buy
2,329
+203
+10% +$75.1K 0.19% 122
2023
Q4 		$749K Sell
2,126
-500
-19% -$177K 0.13% 100
2023
Q3 		$985K Buy
+2,626
New +$1.02M 0.32% 68

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Norden Group's WST Position: Q2 2026 in Review

Norden Group reduced its West Pharmaceutical (WST) stake by 18% in Q2 2026, selling an estimated $232K and leaving 3,409 shares worth $1.22M. The position accounts for 0.1% of the portfolio, ranked #182.

Norden Group first reported a position in WST in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.87M in Q4 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Norden Group held 3,409 shares of West Pharmaceutical worth $1.22M as of Q2 2026.
  • Norden Group sold 759 West Pharmaceutical shares in Q2 2026, an estimated $232K.
  • West Pharmaceutical made up 0.1% of Norden Group's portfolio in Q2 2026, its #182 holding.
  • Norden Group first reported a position in West Pharmaceutical in Q3 2023 and has held it in 12 quarters since.
  • Norden Group's West Pharmaceutical position peaked at $1.87M in Q4 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.